A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment

cs.AI cs.CV Sheng Liu, Long Chen, Zeyun Zhao, Qinglin Gou, Qingyue Wei, Arjun Masurkar, Kevin M. Spiegler, Philip Kuball, Stefania C. Bray, Megan Bernath, Deanna R. Willis, Jiang Bian, Lei Xing, Eric Topol, Kyunghyun Cho, Yu Huang, Ruogu Fang, Narges Razavian, James Zou · Mar 23, 2026
Local to this browser
What it does
Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in multimodal foundation models have improved performance on various clinical tasks, most...
Why it matters
5 percentage points in prospective dementia risk estimation. These results demonstrate Cerebra's potential for interpretable, robust decision support in clinical care.
Review status
The review hit a snag and will retry automatically. The abstract is still available below.
Community signal
0
0 up · 0 down
Sign in to vote with arrows
AI Review Review failed

Review failed. It will be retried automatically.

Abstract

Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in multimodal foundation models have improved performance on various clinical tasks, most existing models remain static, opaque, and poorly aligned with real-world clinical workflows. We present Cerebra, an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis. These outputs are synthesized into a clinician-facing dashboard that combines visual analytics with a conversational interface, enabling clinicians to interrogate predictions and contextualize risk at the point of care. Cerebra supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete. We evaluated Cerebra using a massive multi-institutional dataset spanning 3 million patients from four independent healthcare systems. Cerebra consistently outperformed both state-of-the-art single-modality models and large multimodal language model baselines. In dementia risk prediction, it achieved AUROCs up to 0.80, compared with 0.74 for the strongest single-modality model and 0.68 for language model baselines. For dementia diagnosis, it achieved an AUROC of 0.86, and for survival prediction, a C-index of 0.81. In a reader study with experienced physicians, Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation. These results demonstrate Cerebra's potential for interpretable, robust decision support in clinical care.

Challenge the Review

Pick a starting point or write your own. Challenges run in the background, so you can keep reading while the AI investigates.

No challenges yet. Disagree with the review? Ask the AI to revisit a specific claim.